Stay updated on IO-202 in AML/CMML Clinical Trial
Sign up to get notified when there's something new on the IO-202 in AML/CMML Clinical Trial page.

Latest updates to the IO-202 in AML/CMML Clinical Trial page
- Check2 days agoChange DetectedAdded a PubMed-listed Publications entry for IO-202 (phase 1 study) and updated to v3.0.2; removed the old v3.0.1 revision and the Back to Top link.SummaryDifference4%
- Check9 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check16 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as the introduction of various chemical compounds related to azacitidine and venetoclax. Notably, previous references to specific diseases and certain location details have been removed.SummaryDifference3%
- Check23 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.7%
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.8%
- Check37 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
Stay in the know with updates to IO-202 in AML/CMML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IO-202 in AML/CMML Clinical Trial page.